SHY Therapeutics Email Formats
Biotechnology Research • 
Manhattan, New York, United States • 11-20 Employees
SHY Therapeutics Email Formats
SHY Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@shytherapeutics.com), used 85.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@shytherapeutics.com | 85.7% |
{first initial}.{last name} | j.doe@shytherapeutics.com | 14.3% |
Key Contact at SHY Therapeutics
Yaron Hadari
Co-Founder And Chief Executive Officer
Company overview
| Headquarters | Manhattan, New York, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Biotech, Oncology, Small Molecules, Proteasome |
| Founded | 2015 |
| Employees | 11-20 |
About SHY Therapeutics
SHY is a private, U.S. biotechnology company developing small molecule therapeutics that non-covalently target ATPases and GTPases and modulate their activity. ATPases and GTPases are proteins central to the development of many serious diseases. SHY’s unique molecule portfolio enables us to target ATPases and GTPases associated with serious unmet medical needs, yet often considered undruggable, and to identify and address new treatment targets. SHY will file its first IND in the second half of 2025 for a novel first-in-class cancer therapeutic candidate targeting the proteasome 19S regulatory subunit.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
SHY Therapeutics has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
SHY Therapeutics has never raised funding before.
Germany
United Kingdom
Belgium
South Africa
United Arab Emirates
CanadaFrequently asked questions
4.8
40,000 users
